May 29, 2010
Chris O'MalleyFormer collaborator alleges firm breached its agreement with him and refused to pay royalty income.
More
May 8, 2010
IBJ StaffBloomington led the nation as the No. 1 small city in medical devices and equipment.
More
May 1, 2010
J.K. WallThe university is hoping to find a private company to take over the 5-year-old facility, which formulated and manufactured
small batches of drugs used in clinical trials.
More
April 26, 2010
J.K. WallIndianapolis-based health insurer trades jabs with U.S. health secretary after Reuters story claims insurer deliberately cancels
coverage for breast cancer patients.
More
April 24, 2010
Chris O'MalleyThe upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought
aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo
Inc. bring its artery-measurement
product to market as soon as 2011.
More
April 23, 2010
IBJ StaffThe Indianapolis-based provider of clinical research animals has promoted senior manager Hans Thunem to its top spot.
More
January 12, 2010
J.K. WallRoche Diagnostics named a new CEO for its North American operations Tuesday to replace Michael Tillmann, who resigned on Friday.
More
December 15, 2009
Peter SchnitzlerIndiana University, which has received nearly $600 million from the endowment over the last three decades, will leverage the
new gift to increase its
scientific discoveries and commercialize life science innovations.
More
December 9, 2009
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.
More
December 1, 2009
IBJ StaffJubilant Organosys Ltd. and Indianapolis-based Eli Lilly and Co. extended their collaboration, which began in 2005, by five
years.
More
November 12, 2009
IBJ StaffPrevious gifts from the foundation to the cancer center have been used to hire 10 researchers working on breast cancer.
More
November 7, 2009
Peter SchnitzlerShareholders are starting to make inroads in their effort to turn struggling West Lafayette-based Bioanalytical Systems
Inc. in a new direction.
More
October 21, 2009
J.K. WallEli Lilly and Co. and General Electric Co. say they've made a breakthrough in cancer research that could help Lilly cut the
size and cost of its clinical trials.
More
October 1, 2009
J.K. WallResearchers at IUPUI have been awarded more than $22.3 million in grants by the National Institutes of Health, according to
U.S. Rep. Andre Carson. The money is part of a $5 billion program that was part of the federal stimulus bill approved earlier
this year, and will fund medical research across the country.
More
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
More
July 28, 2009
J.K. WallEli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis
after the drug failed to delay progression of the disease in trial patients.
More
July 20, 2009
J.K. WallFavorable article in prestigious journal could draw attention to Carmel biotech startup.
More
July 20, 2009
J.K. WallThe pharmaceutical industry—which for two decades has given twice as much in campaign donations
to Republicans as Democrats—organized a panel composed mostly of Democrats this month in Indianapolis
to argue its position on health care reform.
More
July 13, 2009
IBJ StaffPurdue University researcher Philip Low, also the chief science officer for West Lafayette-based Endocyte Inc., has developed
a prostate cancer “homing device” to help anti-cancer agents specifically target prostate
cancer tumors.
More
June 22, 2009
IBJ StaffTwo chemistry professors at IUPUI are laboring to create the McDonald's of research laboratoriesa model that's low-cost
and can spread around the world.
More
June 15, 2009
IBJ StaffWhile Eli Lilly and Co. continues to work with a biotech firm on the diabetes medicine Byetta, it's developing a potential
competitor to Byetta all on its own.
More
June 8, 2009
IBJ StaffGreenwood-based Elona Biotechnologies said it has created two subsidiaries to boost its biosimilar/biogeneric/follow-on protein
business.
More
May 25, 2009
Taking science from the laboratory to the commercial market takes too much time and is littered with potential pitfalls along
the way.
More
May 25, 2009
Chris O'MalleyIn a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
More
April 20, 2009
The Indiana chapter of the Arthritis Foundation works to improve lives through leadership in the prevention, control and cure
of arthritis and related diseases.
More
See, I told u Indyman and Dipsicle....this 8 days is overkill. It's barely worth a weekend....great job Tony George! Your dream has been fulfilled....he fans want the I r l back. Thats how good it was.....and that sucked.
I have been in training for a short time now but right off I can see that safety and quality are the number one issues, my experience as of late has been a positive one, the employees along with Jeff the plant manager and the operation supervisor as well as the engineers are a highly motivated group of people, what an asset for the area to have and for company's in need of a quality metal products.
Pimlico
While I understand the severity of their actions as well as everyones eagerness to hold them responsible for thier lost funds, these gentlemen did know how to make money. Dispite thier poor decisions over the ownership of Fair they had made several wise investments which paid them greatly. This proves they do have the potential to rebuild so they can repay. I do not feel they should live the life of luxuary but given an opportunity could they find ways of repaying the debts? They are doing nothing now but being a burden on tax payers. Just a thought!!!!!
You guys have some "interesting" comments to say the least. I hope you will call in and share those opinions starting June 1. I'm looking forward to having you on the air.